Intercellular adhesion molecule-1 polymorphisms in patients with Behçet disease: A meta-analysis

Abstract

Objectives. To examine the association between the Intercellular adhesion molecule-1 (ICAM1) Polymorphisms and Behçet's disease.

Methods. MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials for original studies up to July 31, 2012 were searched for relevant studies. All pooled odds ratios (ORs) were derived from either fixed or random-effects model with its 95% confidence intervals (CI).

Results. Five studies met the inclusion criteria. Overall, ICAM1 E469 (OR = 1.45, 95% CI = 1.06–1.97), genotype ICAM1 469 E/E (OR = 1.45, 95% CI = 1.09–1.94), ICAM1 241 G/R (OR = 3.65, 95% CI = 1.69–7.89), had significant associations with Behçet's disease. A significant association was found between the presence of skin lesions and genotype ICAM1 469 E/E (OR = 3.52, 95% CI = 1.62–7.66).

Conclusions. Behçet's disease was associated with the ICAM1 E469, genotype ICAM1 469 E/E, ICAM1 241 G/R polymorphisms in different ethnic groups. Among patients, genotype ICAM1 469 E/E had a significant association with skin lesion.

Keywords:

• Behçet's disease
• Intercellular adhesion molecule-1
• Meta-analysis
• Polymorphisms

Acknowledgments

None.

Conflict of interest

None.